In vitro farnesoid X receptor ligand sensor assay using surface plasmon resonance and based on ligand-induced coactivator association

Journal of Steroid Biochemistry and Molecular Biology

Volumn 87, Issue 4-5, 2003, Pages 247-252

  Fujino, Tomofumi ^a   Sato, Yoji ^a   Une, Mizuho ^b   Kanayasu Toyoda, Toshie ^a   Yamaguchi, Teruhide ^a   Shudo, Koichi ^a   Inoue, Kazuhide ^a   Nishimaki Mogami, Tomoko ^a,c  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c Division of Biosignaling   (Japan)

Author keywords

Coactivator recruitment; Farnesoid X receptor; Ligand binding; Surface plasmon resonance

Indexed keywords

CHENODEOXYCHOLIC ACID; FARNESOID X RECEPTOR; LIGAND; SULFONIC ACID DERIVATIVE;

ARTICLE; BINDING AFFINITY; BIOSENSOR; DISSOCIATION CONSTANT; IN VITRO STUDY; KINETICS; LIGAND BINDING; PROTEIN INTERACTION; RELIABILITY; SURFACE PLASMON RESONANCE;

EID: 0347362548     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2003.09.008     Document Type: Article

References (30)

1. Forman B.M., Goode E., Chen J., Oro A.E., Bradley D.J., Perlmann T., Noonan D.J., Burka L.T., McMorris T., Lamph W.W. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 81:1995;687-693.
2. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
3. Seol W., Choi H.S., Moore D.D. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9:1995;72-85.
4. Zavacki A.M., Lehmann J.M., Seol W., Willson T.M., Kliewer S.A., Moore D.D. Activation of the orphan receptor RIP14 by retinoids. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7909-7914.
5. Makishima M., Okamoto A.Y., Repa J.J., Tu H., Learned R.M., Luk A., Hull M.V., Lustig K.D., Mangelsdorf D.J., Shan B. Identification of a nuclear receptor for bile acids. Science. 284:1999;1362-1365.
6. Parks D.J., Blanchard S.G., Bledsoe R.K., Chandra G., Consler T.G., Kliewer S.A., Stimmel J.B., Willson T.M., Zavacki A.M., Moore D.D., Lehmann J.M. Bile acids: natural ligands for an orphan nuclear receptor. Science. 284:1999;1365-1368.
7. Wang H., Chen J., Hollister K., Sowers L.C., Forman B.M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell. 3:1999;543-553.
8. Chiang J.Y., Kimmel R., Weinberger C., Stroup D. Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J. Biol. Chem. 275:2000;10918-10924.
9. Chiang J.Y.L. Regulation of bile acid synthesis. Front Biosci. 3:1998;D176-D193.
10. Russell D.W., Setchell K.D. Bile acid biosynthesis. Biochemistry. 31:1992;4737-4749.
11. Berger J., Bailey P., Biswas C., Cullinan C.A., Doebber T.W., Hayes N.S., Saperstein R., Smith R.G., Leibowitz M.D. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology. 137:1996;4189-4195.
12. Willson T.M., Cobb J.E., Cowan D.J., Wiethe R.W., Correa I.D., Prakash S.R., Beck K.D., Moore L.B., Kliewer S.A., Lehmann J.M. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 39:1996;665-668.
13. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M.G., Wahli W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11:1997;779-791.
14. Glass C.K., Rose D.W., Rosenfeld M.G. Nuclear receptor coactivators. Curr. Opin. Cell Biol. 9:1997;222-232.
15. Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
16. Drake K.A., Zhang J.H., Harrison R.K., McGeehan G.M. Development of a homogeneous, fluorescence resonance energy transfer-based in vitro recruitment assay for peroxisome proliferator-activated receptor delta via selection of active LXXLL coactivator peptides. Anal. Biochem. 304:2002;63-69.
17. Ou J., Tu H., Shan B., Luk A., DeBose-Boyd R.A., Bashmakov Y., Goldstein J.L., Brown M.S. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. U.S.A. 98:2001;6027-6032.
18. Bramlett K.S., Yao S., Burris T.P. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids. Mol. Genet. Metab. 71:2000;609-615.
19. Burakov D., Wong C.W., Rachez C., Cheskis B.J., Freedman L.P. Functional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex. J. Biol. Chem. 275:2000;20928-20934.
20. Nishikawa J., Saito K., Goto J., Dakeyama F., Matsuo M., Nishihara T. New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicol. Appl. Pharmacol. 154:1999;76-83.
21. Treuter E., Johansson L., Thomsen J.S., Warnmark A., Leers J., Pelto-Huikko M., Sjoberg M., Wright A.P., Spyrou G., Gustafsson J.A. Competition between thyroid hormone receptor-associated protein (TRAP) 220 and transcriptional intermediary factor (TIF) 2 for binding to nuclear receptors. Implications for the recruitment of TRAP and p160 coactivator complexes. J. Biol. Chem. 274:1999;6667-6677.
22. Myszka D.G. Improving biosensor analysis. J. Mol. Recognit. 12:1999;279-284.
23. Kihira K., Yoshii M., Okamoto A., Ikawa S., Ishii H., Hoshita T. Synthesis of new bile salt analogues, sodium 3 alpha, 7 alpha-dihydroxy- 5 beta-cholane-24-sulfonate and sodium 3 alpha, 7 beta-dihydroxy-5 beta- cholane-24-sulfonate. J. Lipid Res. 31:1990;1323-1326.
24. Urizar N.L., Liverman A.B., Dodds D.T., Silva F.V., Ordentlich P., Yan Y., Gonzalez F.J., Heyman R.A., Mangelsdorf D.J., Moore D.D. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science. 296:2002;1703-1706.
25. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736.
26. Karlsson R., Michaelsson A., Mattsson L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J. Immunol. Methods. 145:1991;229-240.
27. Laffitte B.A., Kast H.R., Nguyen C.M., Zavacki A.M., Moore D.D., Edwards P.A. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J. Biol. Chem. 275:2000;10638-10647.
28. Goodwin B., Gauthier K.C., Umetani M., Watson M.A., Lochansky M.I., Collins J.L., Leitersdorf E., Mangelsdorf D.J., Kliewer S.A., Repa J.J. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc. Natl. Acad. Sci. U.S.A. 100:2003;223-228.
29. Kim H.G., Une M., Hino A., Wada H., Yoshii M., Kuramoto T., Fujimura K. Bile acid sulfonate and 7-alkylated bile acid analogs: effect on intestinal absorption of taurocholate and cholesterol 7alpha-hydroxylase activity in cultured rat hepatocytes. Steroids. 65:2000;24-28.
30. Kim H.G., Une M., Kuramoto T., Noshiro M., Fujimura K. Hypocholesterolemic effect of bile acid sulfonate analogs in hamsters. Biol. Pharm. Bull. 24:2001;218-220.